Recommended Topical Treatments for Psoriasis
Topical corticosteroids are the first-line treatment for mild to moderate psoriasis, with coal tar preparations also strongly recommended (strength of recommendation: A) for mild to moderate disease. 1
First-Line Topical Therapies
Topical Corticosteroids
Potency selection based on location:
- Class 1 (Ultrahigh-potency): Clobetasol propionate 0.05%, halobetasol propionate for resistant plaques 2
- Class 2-5 (High to moderate potency): Betamethasone dipropionate, triamcinolone acetonide for trunk and extremities 2
- Class 6-7 (Low potency): Hydrocortisone, desonide for face, intertriginous areas, and children 2
Application frequency:
Special formulations:
Vitamin D Analogs
- Calcipotriene 0.005% ointment is FDA-approved for plaque psoriasis in adults 6
- Can be used as monotherapy or in combination with corticosteroids
- Less rapid in onset than corticosteroids but safer for long-term use
Combination Therapy Approach
Recommended sequential therapy: Clobetasol propionate for 2 weeks followed by calcipotriene is superior to calcipotriene alone 7
Combination therapy benefits:
- Vitamin D analogs with mid/high-potency corticosteroids (Strength of recommendation: A) 2
- Decreases treatment duration
- Increases remission length
- Reduces itching and desquamation
- Reduces total body surface area involvement
Other Recommended Topical Agents
Coal Tar Preparations
- Strongly recommended for mild to moderate psoriasis (Strength of recommendation: A) 1
- Can be used alone or in combination with phototherapy (Goeckerman therapy) 1
- Caution: May cause irritation, folliculitis, and has an unpleasant odor that reduces adherence 1
Salicylic Acid
- Can be used for 8-16 weeks for mild to moderate psoriasis (Strength of recommendation: B) 1
- Particularly useful for thick, scaly plaques
- Combination with topical corticosteroids recommended for moderate to severe psoriasis (BSA ≤20%) 1
Anthralin (Dithranol)
- Recommended for 8-12 weeks for mild to moderate psoriasis (Strength of recommendation: B) 1
- Start at 0.1% concentration and increase as tolerated
- Short contact therapy (up to 2 hours per day) recommended to limit side effects 1
Topical Calcineurin Inhibitors
- First-line for intertriginous areas 2
- Alternative to corticosteroids for facial and genital psoriasis
Special Considerations
Anatomical Location
- Scalp: High-potency corticosteroid solutions or foams 4
- Intertriginous areas: Topical calcineurin inhibitors or low-potency corticosteroids 2
- Genital psoriasis: Requires special attention due to psychological impact 2
Pediatric Patients
- Use lower potency corticosteroids 2
- Young children (0-6 years) are vulnerable to HPA axis suppression 2
- Avoid high-potency corticosteroids in children when possible
Monitoring and Assessment
- Evaluate response after 4 weeks of topical therapy 2
- Monitor for adverse effects:
Common Pitfalls to Avoid
Overuse of high-potency corticosteroids:
Inappropriate vehicle selection:
- Choose ointments for thick plaques and dry skin
- Use solutions, foams, or shampoos for scalp psoriasis 5
Poor adherence:
- Consider patient preference for vehicle (ointment vs. cream vs. foam)
- Newer formulations may improve adherence compared to traditional ointments 5
Pregnancy considerations:
- Avoid coal tar preparations during pregnancy and lactation 1
- Use lowest effective potency of corticosteroids when needed